detection of cell surface antigens by the cellular enzyme-linked immunosorbent assay (celisa)

1
Abstracts ~77 DETECTION OF CELL SURFACE A~"~IGENS BY THE CELLUIARENZY~-LZT~KED IHMUNO~OHBI~TA~A¥ (CELISA) R. Morris t P. Thomas I & R. Hong, Depts. of Surg. & PedSo UnJvo of WIS. Two novel techniques that exploit the invention of the enzyme Immunoasss¥ ~ave been designed to detect cell surface antlg~ns. Inltxally a suspenslo~- phase mzeroCELISA was used to measure the bzndtn~ of poly- and monn~peelrJe ~HLAsera (Sul) to human lymphocytes (~0,000 cells) in V-bottom~iero- plates. A goat~human IgG eovalently lln~,ed to alkaline phosphatase (CAH- AP) was used as an Jndlrect Indicator of hound ~HLAant~body° Cells~ere washed ~ree ofurtouniantzbodzes by repeated centrz£~atlonandresuspen- ston. The colored enzymatic product (formed by the action of the enzyme on the added colorless substrate) xn the wells was ~easured speetrophoto~etrie- ally. Using standard typln~ sera and cells, the CEL!SA was specific and more sensitive than the mzcrodroplet cytotoxzc~ty test (MCT), e.g. for a polyspeczfxe ~HIAantxbody MCT tzter = ~, CELISAtlter • 1/lO00; for a monospeezfze ~HLA antibody MCT txter = 1/1, CELISA titer~ 1/200. A falter-phase CELISA was developed that uses flat bottom mlerotiter plates in which a filter ~orms the bottom of each well. This assay requires as fev as 12,500 cells and as little as 5 ul of antibody. Pas~xng wash buffer past the cells on the £11tez effectively washes out unbo~d antibodies. Bindin~ of homologous and heterologous (mouse monoclonal) eHIA antibodies to lympho- eytes has been detected In addition, ~xndzng o~ a l~totxnylatedmonoelonal antibody to a human T-cell differentiation antigen has been observed with avldzn - AP. The CE~,ISA is a sunple, rapid, sensltxve, specifie micro- technique for objectively detecting cell surface antzgens. Therefore, the CELISA may have broad research and cl/nzeal application. IN SEARCH OF THE H[CHANISHBY HHICHBLOOD TRANSFUSIONS IHPGOVE KIDNEYGRAFTSUR- VIVAL. D.J. Norman and J.M. Barr~, Departments of Medtctn¢ and Surgery, University of Oregon Health Sciences center, Portland, Oregon. To Improve our understanding of the mechanisms by which blood transfusions Improve renal a11ograft survival, we began a prospective study tn December 1979 using HLA typed blood donors. Prospective recipients of first cadaver grafts who had not received blood products were transfused with one unit of packed cells from each of five HLA typed donors. 91ood donors who were mismatched for as many HLA-A and -B antigens as posszble were selected and the blood was always transfused within four days Of donation. Fifteen pa- tients have completed the protocol and 10 have been transplanted. Lympho- cytotoxtc antibodies developed transiently or pemanently tn 11 patients (735}. Only one patient (7~) doveloped antibodies whtch killed >15~ of a lymphocyte panel. This patient kf11$ >99~ of the panel and since being placed on the Cadaver list has been crossmatch (+) with six prospective do- nors. All of the other 10 patients who have been put on the cadaver Hst have received kidneys and, of the Z5 crossmatches perfumed on prospective donors, only one was positive. Actuartal graft survival is lOO~at 10 months. Seven of the 10 patients received only HLA mismatched blood~hfle three required 2, 3 and 5 additional units, respectively. Nine patients .ere transrlanted from donors who shared at least one HLA-A and -B antigen with their blood donors. One shared four antigens, four shared two and three shared one. Because of: I) the low incidence of broad|y reactive 3ymphocytotoxtns, 2) low Incidence of positive cro;matches with prospec- tive donors, and 3) exce]lent graft survival, our data suggest that fresh HtA m|smatched transfusions induce a fom of Immunologic unresponsiveness. THREE KINDS UP B CELL ANTIBODIES IN KIDNEY TRANSPLANTRECIPIENTS. Cabriel Nunez 9~ Peter Sta~tny~ Department of Internal Mediczne. The University of Texas Health Science Center at Dallas. Texas. Antibodies against B cells in recipients of k~doey allografts are known to be "~eterogeneous. Some are directed aaaznst HLA-DR antigens, others have been shown to react with non-DR surface determinants such as i~munoglobulln. We have developed a procedure for identifying B cell antibodies by blocking their reactions wlth non-complement-flxing reagents prior to cytotoxiclty testing. A monoclonal anti-DR (~DR) was used to identify anti-DR auti-

Upload: builien

Post on 02-Jan-2017

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Detection of cell surface antigens by the cellular enzyme-linked immunosorbent assay (CELISA)

Abstracts ~77

DETECTION OF CELL SURFACE A~"~IGENS BY THE CELLUIARENZY~-LZT~KED IHMUNO~OHBI~TA~A¥ (CELISA) R. Morris t P. Thomas I & R. Hong, Depts. of Surg. & PedSo UnJvo of WIS.

Two novel techniques that exploit the invention of the enzyme Immunoasss¥ ~ave been de s igned to d e t e c t c e l l s u r f a c e a n t l g ~ n s . I n l t x a l l y a suspenslo~- phase mzeroCELISA was used t o measure the bzndtn~ o f p o l y - and monn~peelrJe ~ H L A s e r a (Sul ) to human lymphocytes (~0,000 c e l l s ) in V - b o t t o m ~ i e r o - plates. A goat~human IgG eovalently lln~,ed to alkaline phosphatase (CAH- AP) was used as an Jndlrect Indicator of hound ~HLAant~body° Cells~ere washed ~ree ofurtouniantzbodzes by repea ted centrz£~atlonandresuspen- s t o n . The co lo r ed enzymat ic p roduc t (formed by t he a c t i o n o f t h e enzyme on t he added c o l o r l e s s s u b s t r a t e ) xn t he w e l l s was ~easured s p e e t r o p h o t o ~ e t r i e - a l l y . Us ing s t a n d a r d t yp ln~ s e r a and c e l l s , t h e CEL!SA was s p e c i f i c and more s e n s i t i v e than t h e mzcrodrople t cy to toxzc~ ty t e s t (MCT), e . g . f o r a po ly specz fxe ~ H I A a n t x b o d y MCT t z t e r = ~ , C E L I S A t l t e r • 1/ lO00; f o r a monospeezfze ~HLA an t i body MCT t x t e r = 1 / 1 , CELISA t i t e r ~ 1/200. A f a l t e r - p h a s e CELISA was developed t h a t u s e s f l a t bot tom m l e r o t i t e r p l a t e s i n which a f i l t e r ~orms t h e bot tom o f each w e l l . Th is a s s a y r e q u i r e s a s f ev a s 12,500 c e l l s and a s l i t t l e as 5 u l o f an t ibody . Pas~xng wash b u f f e r p a s t t he c e l l s on t h e £11tez e f f e c t i v e l y washes ou t u n b o ~ d a n t i b o d i e s . Bindin~ o f homologous and h e t e r o l o g o u s (mouse monoclonal) eHIA a n t i b o d i e s t o lympho- e y t e s has been d e t e c t e d In a d d i t i o n , ~xndzng o~ a l~ to txny la t edmonoe lona l an t ibody to a human T - c e l l d i f f e r e n t i a t i o n a n t i g e n has been observed wi th av ldzn - AP. The CE~,ISA i s a s u n p l e , r a p i d , s e n s l t x v e , s p e c i f i e m ic ro - t e c h n i q u e fo r o b j e c t i v e l y d e t e c t i n g c e l l s u r f a c e a n t z g e n s . T h e r e f o r e , t h e CELISA may have broad research and cl/nzeal application.

IN SEARCH OF THE H[CHANISH BY HHICH BLOOD TRANSFUSIONS IHPGOVE KIDNEY GRAFT SUR- VIVAL. D.J. Norman and J.M. Barr~, Departments of Medtctn¢ and Surgery, University of Oregon Health Sciences center, Portland, Oregon.

To Improve our understanding of the mechanisms by which blood transfusions Improve renal a11ograft survival, we began a prospective study tn December 1979 using HLA typed blood donors. Prospective recipients of f i r s t cadaver grafts who had not received blood products were transfused with one unit of packed cells from each of f ive HLA typed donors. 91ood donors who were mismatched for as many HLA-A and -B antigens as posszble were selected and the blood was always transfused within four days Of donation. Fifteen pa- t ients have completed the protocol and 10 have been transplanted. Lympho- cytotoxtc antibodies developed transiently or pemanently tn 11 patients (735}. Only one patient (7~) doveloped antibodies whtch ki l led >15~ of a lymphocyte panel. This patient kf11$ >99~ of the panel and since being placed on the Cadaver l i s t has been crossmatch (+) with six prospective do- nors. All of the other 10 patients who have been put on the cadaver Hs t have received kidneys and, of the Z5 crossmatches perfumed on prospective donors, only one was positive. Actuartal graft survival is lOO~at 10 months. Seven of the 10 patients received only HLA mismatched blood~hfle three required 2, 3 and 5 additional units, respectively. Nine patients .ere transrlanted from donors who shared at least one HLA-A and -B antigen with their blood donors. One shared four antigens, four shared two and three shared one. Because of: I) the low incidence of broad|y reactive 3ymphocytotoxtns, 2) low Incidence of positive cro;matches with prospec- t ive donors, and 3) exce]lent graft survival, our data suggest that fresh HtA m|smatched transfusions induce a fom of Immunologic unresponsiveness.

THREE KINDS UP B CELL ANTIBODIES IN KIDNEY TRANSPLANT RECIPIENTS. Cabr ie l Nunez 9 ~ Pe t e r Sta~tny~ Department of I n t e r n a l Mediczne. The U n i v e r s i t y of Texas Heal th Science Center a t D a l l a s . Texas .

An t ibod ies a g a i n s t B c e l l s in r e c i p i e n t s of k~doey a l l o g r a f t s a re known to be "~eterogeneous. Some a r e d i r e c t e d aaazns t HLA-DR a n t i g e n s , o t h e r s have been shown to r e a c t wi th non-DR s u r f a c e de te rminan t s such a s i~munoglobulln. We have developed a procedure fo r i d e n t i f y i n g B c e l l a n t i b o d i e s by b lock ing t h e i r r e a c t i o n s wl th non-complement - f lx ing r e a g e n t s p r i o r to c y t o t o x i c l t y t e s t i n g . A monoclonal ant i -DR (~DR) was used to i d e n t i f y ant i-DR a u t i -